Welcome to our dedicated page for Mistras Group SEC filings (Ticker: MG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Mistras Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Mistras Group's regulatory disclosures and financial reporting.
Mistras Group, Inc. reported that President and CEO Natalia Shuman-Fabbri acquired a grant of 101,190 shares of Common Stock on February 25, 2026. The shares were awarded at a stated price of $0.00 per share, bringing her direct holdings to 126,190 shares after the transaction.
Mistras Group, Inc. Executive Chairman Manuel N. Stamatakis reported an acquisition of common stock through an equity award. On the reported date, he received 86,310 shares of Mistras Group common stock at a stated price of $0.00 per share, described as a grant or award rather than an open-market purchase. Following this transaction, his directly held common stock ownership increased to 510,609 shares.
Mistras Group Sr. EVP and CFO Edward J. Prajzner reported offsetting equity transactions in company stock. On February 25, 2026, he acquired 37,202 shares of common stock as a grant or award at $0.00 per share, increasing his direct holdings.
On February 28, 2026, he disposed of 1,303 shares of common stock at a price of $15.28 per share in a tax-withholding disposition, used to satisfy tax obligations on equity compensation. After these transactions, he directly held 154,920 common shares.
Mistras Group EVP & Chief Operating Officer Hammad Hanei Wail reported mixed equity transactions in company stock. On February 25, 2026, he acquired 29,762 shares of common stock at a price of $0.0000 per share as a grant or award. A footnote explains this represents restricted stock units earned from a performance award that will vest on December 31 in 2026, 2027, 2028 and 2029. Following this grant, his directly owned stake increased to 88,357 shares. The filing also reports a prior disposition to the issuer on March 25, 2025, where 6,384 shares of common stock were surrendered at $10.7900 per share, leaving 58,595 shares directly owned after that transaction.
Coggins Eileen Mary reported acquisition or exercise transactions in this Form 4 filing.
Mistras Group, Inc. executive Eileen Mary Coggins, EVP and General Counsel, reported an equity compensation award in the form of 7,242 shares of common stock. The award represents restricted stock units earned from a performance award and was granted at a price of $0.00 per share. These units vest in four equal installments of 25% each on December 31 of 2026, 2027, 2028 and 2029. Following this grant, Coggins directly holds a total of 22,242 shares of Mistras Group common stock.
Mistras Group reported mixed but margin-focused results for Q4 and full-year 2025. Fourth-quarter revenue was $181.5 million, up 5.1%, with gross margin improving to 28.4%. Net income was $3.9 million, or $0.12 per diluted share, while Adjusted EBITDA reached a record $24.8 million, up 18.2% with a 13.7% margin.
For 2025, revenue was $724.0 million, slightly below 2024, but gross margin rose to 28.2%. Net income was $16.8 million, or $0.53 per diluted share, versus $19.0 million and $0.60 a year earlier, while record Adjusted EBITDA increased 10.5% to $91.1 million with a 12.6% margin.
Operating cash flow declined to $33.0 million and free cash flow to $3.8 million, mainly from higher receivables and capital spending. Gross debt was $178.0 million and net debt $150.0 million, with a bank leverage ratio of about 2.5x, below the 3.75x maximum. The company recorded $12.7 million of 2025 reorganization and other costs and highlighted plans to keep investing in higher-return, technically differentiated opportunities in 2026.
Mistras Group EVP and Chief Commercial Officer Gennaro A. D'Alterio reported equity compensation and related tax transactions. On February 25, 2026, he received a grant of 19,905 shares of common stock. On February 28, 2026, 655 and 862 shares were disposed of to cover tax withholding, leaving direct holdings just under 48,000 shares after these movements.
Mistras Group, Inc. disclosed an initial statement of beneficial ownership on Form 3 for the 2025 Irrevocable Two-Year Grantor Retained Annuity Trust of Aspasia F. Vahaviolos, which is identified as a more than 10% owner. The trust reports direct ownership of 5,251,358 shares of common stock following the reported position. The filing does not show any new buy or sell transaction, but rather records the trust’s existing holdings as of the reporting date.
Mistras Group, Inc. major shareholder Aspasia Felice Vahaviolos reported a bona fide gift of 5,251,358 shares of common stock at no stated price per share. After this gift transfer, she directly owns 854,292 Mistras Group common shares.
Mistras Group Executive Chairman and director Manuel Stamatakis reported an equity grant from the company. On 01/02/2026, he acquired 40,000 shares of common stock at a price of $0, reported as an award of restricted stock units that will vest 100% on the first anniversary of the grant date. Following this transaction, he beneficially owns 424,299 shares of Mistras Group common stock in direct ownership. This Form 4/A is described as an amendment filed solely to correct an administrative error on the signature line, with no change to the reported award terms.